Corpus Intelligence IC Memo — MERCY MEDICAL CENTER 2026-04-26 05:27 UTC
IC Memo — MERCY MEDICAL CENTER
Investment Committee Memorandum | MD | 173 beds | Grade B | EBITDA uplift $41.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY MEDICAL CENTER

CCN 210008 | BALTIMORE CITY, MD | 173 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MERCY MEDICAL CENTER is a 173-bed suburban community hospital in BALTIMORE CITY, MD with $561.3M in net patient revenue and a -3.3% operating margin. The hospital serves a payer mix of 20.2% Medicare, 4.0% Medicaid, and 75.8% commercial.

Thesis: Undervalued. Our ML models identify $41.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.3% to 4.1% (+736bps).

Net Revenue HCRIS$561.3M
Current EBITDA COMPUTED$-18.4M
Operating Margin COMPUTED-3.3%
Occupancy HCRIS74.4%
Revenue / Bed COMPUTED$3.2M
Net-to-Gross HCRIS85.0%
Distress Probability ML45.5%

2. Market Context & Competitive Position

59
MD Hospitals
-8.3%
State Median Margin
33
Comparable Hospitals

MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -3.3% places it above the state median. Among 33 size-comparable peers (86-346 beds), the median margin is -7.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (86-346), prioritizing same-state peers. 33 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY MEDICAL CENTER (Target)MD173$561.3M-3.3%
ST. AGNES HOSPITALMD183$506.7M-12.2%
TIDALHEALTH PENINSULA REGIONALMD230$493.4M0.8%
BALTIMORE WASHINGTON MEDICAL CMD314$440.2M-7.9%
GREATER BALTIMORE MEDICAL CENTMD265$420.3M-48.5%
MEDSTAR UNION MEMORIAL HOSPITAMD191$409.3M-8.7%
ST. JOSEPH MEDICAL CENTERMD225$398.0M-3.2%
MERITUS MEDICAL CENTERMD265$396.2M1.5%
FREDERICK MEMORIAL HOSPITALMD279$388.7M-6.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $41.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$11.8M+210bp18mo
Cost to Collect4.5%2.5%$11.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$11.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$6.8M+122bp9mo
Clean Claim Rate88.0%96.0%$359K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$11.8M
Cost to Collect
$11.2M
Denial Rate Reduction
$11.1M
A/R Days Reduction
$6.8M
Clean Claim Rate
$359K
Total EBITDA Uplift$41.3M
Current EBITDA$-18.4M
+ RCM Uplift+$41.3M
Pro Forma EBITDA$22.9M
Current Margin-3.3%
Pro Forma Margin4.1%
WC Released (1x)$21.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-28.4M$291.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-28.4M$311.4M0.00x-100.0%
Bull Case9.0x11.0x$-25.5M$438.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-25.5M$470.9M0.00x-100.0%
Bear Case11.0x10.0x$-31.2M$94.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-31.2M$93.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 33 hospitals with 86-346 beds
  • Same-state prioritization (n=34)
  • Comp margins: P25=-12.8% / P50=-7.9% / P75=-1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.